FDA issues draft guidelines for STAT-C/DAA development ...

The FDA has just issued a draft of potential guidelines for companies developing STAT-C / DAA drugs for Hepatitis C.  This is for comment only, the FDA will issue their final guidelines toward the end of the year.  The draft can be viewed on the FDA website.